Neupulse

Nottingham, United Kingdom Founded: 2021 • Age: 5 yrs
Develops wearable devices and apps to manage Tourette Syndrome tics and urges.
Request Access

About Neupulse

Neupulse is a company based in Nottingham (United Kingdom) founded in 2021. It operates as a D2C. Neupulse has raised $4.95 million across 3 funding rounds from investors including Midlands Engine and Eos. Neupulse offers products and services including Wearable Wrist Device and Neutrack App. Neupulse operates in a competitive market with competitors including Centivo, Access Healthcare, MultiPlan, Omega Healthcare and Light Wave Dental, among others.

  • Headquarter Nottingham, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Neurotherapeutics Ltd
  • Date of Incorporation 12 Feb, 2021
  • Jurisdiction NOTTINGHAM, ENGLAND
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4.95 M (USD)

    in 3 rounds

  • Latest Funding Round
    $642.15 K (USD), Seed

    Jul 31, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Neupulse

Neupulse offers a comprehensive portfolio of products and services, including Wearable Wrist Device and Neutrack App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Delivers electrical pulses to reduce tics in Tourette Syndrome patients.

Monitors Tourette Syndrome symptoms and external factors over time.

People of Neupulse
Headcount 1-10
Employee Profiles 4
Employee Profiles
People
Barbara Morera
Chief Research Officer
People
Kyran Latham
Office Manager
People
Paul Cable
Chief Executive Officer
People
David Moser
Chief Technology Officer

Unlock access to complete

Funding Insights of Neupulse

Neupulse has successfully raised a total of $4.95M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $642.15 thousand completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Seed — $642,150
  • First Round

    (20 Jan 2023)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2024 Amount Seed - Neupulse Valuation Midlandsengine
Mar, 2024 Amount Seed - Neupulse Valuation Eos Advisory
Jan, 2023 Amount Seed - Neupulse Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Neupulse

Neupulse has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Midlands Engine and Eos. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment in science and technology is managed by Eos.
Founded Year Domain Location
A regional partnership focused on economic growth in the Midlands.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Neupulse

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Neupulse

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Neupulse Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Neupulse

Neupulse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Centivo, Access Healthcare, MultiPlan, Omega Healthcare and Light Wave Dental, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of self funded health plan
domain founded_year HQ Location
Provider of revenue cycle management, BPO, IT, and finance and accounting services
domain founded_year HQ Location
Medical payment integrity and analytics services are provided by MultiPlan.
domain founded_year HQ Location
Healthcare outsourcing services are provided to various sectors.
domain founded_year HQ Location
Dental practice brokerage services are provided to facilitate transactions.
domain founded_year HQ Location
Software solutions for laboratory diagnostics are provided to healthcare.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Neupulse

Frequently Asked Questions about Neupulse

When was Neupulse founded?

Neupulse was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Neupulse located?

Neupulse is headquartered in Nottingham, United Kingdom.

Is Neupulse a funded company?

Neupulse is a funded company, having raised a total of $4.95M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.1M, raised on Jan 20, 2023.

What does Neupulse do?

Neupulse, based in Nottingham, England, focuses on creating innovative non-drug treatments for Tourette Syndrome. They develop a wearable wrist device that uses gentle median nerve stimulation to reduce tics and urges. The company also works on a mobile app for symptom monitoring and conducts clinical trials with participants in the UK. Collaborating with healthcare organizations, they aim to provide accessible options for symptom management through research and device sales.

Who are the top competitors of Neupulse?

Neupulse's top competitors include Centivo, Access Healthcare and Rennova Health.

What products or services does Neupulse offer?

Neupulse offers Wearable Wrist Device and Neutrack App.

Who are Neupulse's investors?

Neupulse has 2 investors. Key investors include Midlands Engine, and Eos.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available